Two small clinical trials tested the safety of injecting stem cells into the brains of Parkinson's patients and found no ...

Scientists at the University of California, Riverside, have discovered how adult stem cells retain their regenerative power.

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

Stem-cell treatments Mesenchymal stromal cells (MSCs) are adult stem cells that can be sourced relatively easily from various body tissues including adipose (fat) tissue and the umbilical cord.

are typically adult skin or blood cells that have been reprogrammed in a lab to become like embryonic stem cells, which are ...

Adult stem cells can be altered to have the ... There’s no FDA-approved stem cell therapy for Parkinson’s, but clinical ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

Okano noted that the medical trial used induced pluripotent stem (iPS) cells, which basically means they are normal adult cells which have been reprogrammed to act like the embryonic stem cells ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.

A crucial requirement for MSC-based OA therapy is the delivery of the cells to the defect site. Direct intra-articular injection might be possible in early stages of the disease when the defect is ...

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...